Regression modeling showed statistically significant associations with the use of either carbamazepine (CBZ) or oxcarbazepine (OCBZ), especially for women; odds ratio 15.0 (95% confidence interval 4.6 to 49.5) Conclusion: CH is observed more often in individuals taking CBZ or OCBZ, especially women.
Greiningin sýndi marktæk tengsl milli MSB og notkunar á annaðhvort karbamazepín eða oxkarbazepín, sérstaklega hjá konum (áhættuhlutfall (odds ratio) 15,0 með 95% öryggisbil 4,6 til 49,5). Ályktun: MSB er algengari meðal einstaklinga sem taka karbamazepín eða oxkarbazepín, sérstaklega meðal kvenna.